Diazoxide

This classification denotes a vasodilating agent with the molecular formula C8H7ClN2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O5CB12L4FN, chemically known as 7-chloro-3-methyl-2h-1,2,4-benzothiadiazine 1,1-dioxide but generally known as diazoxide, which bears US NIH Compound Identifier 3019. European Medicines Agency schedules Diazoxide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07071MIG. The term DIAZOXIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules diazoxide in its Anatomical Therapeutic Chemical (ATC) Classification. DIAZOXIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diazoxide under HS 29349990 and SITC 51579. As of Q4 2014, DIAZOXIDE remains the US FDA Preferred Term for this commodity. Diazoxide bears US NLM identifiers UMLS ID C0012022 and NCI Concept Code C428. SMILES: Clc1cc2S(=O)(=O)N=C(Nc2cc1)C.